Are you Dr. Saullo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 62 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
40 Duke Medicine Cir
Durham, NC 27710Phone+1 919-684-8111
Summary
- Dr. Jennifer Saullo, MD is an infectious disease specialist in Durham, North Carolina. She is currently licensed to practice medicine in North Carolina and New York. She is affiliated with Duke University Hospital and is a Medical Instructor in the Department of Medicine at Duke University School of Medicine.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Infectious Disease, 2008 - 2011
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2004 - 2007
- The University of Texas Health Science Center at San AntonioClass of 2004
Certifications & Licensure
- NC State Medical License 2011 - 2025
- NY State Medical License 2006 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 22 citationsOral and Inhaled Ribavirin Treatment for Respiratory Syncytial Virus Infection in Lung Transplant Recipients.Nitipong Permpalung, Tany Thaniyavarn, Jennifer L. Saullo, Sana Arif, Rachel Miller
Transplantation. 2020-06-01 - 3 citationsReal-World Experience With Maribavir for Treatment of Cytomegalovirus Infection in High-Risk Solid Organ Transplant Recipients.Bin Ni, Cameron R Wolfe, Sana Arif, Manuela Carugati, Madeleine R Heldman
Open Forum Infectious Diseases. 2024-07-01 - 6 citationsUse of Letermovir for Primary and Secondary Cytomegalovirus Prophylaxis in Abdominal Organ Transplantation: A Single Center Experience.Dima Ibrahim, Jennifer Byrns, Eileen Maziarz, Barbara D Alexander, Jennifer L Saullo
Journal of Pharmacy Practice. 2024-06-01
Press Mentions
- Risks vs. Benefits of the COVID VaccineJanuary 22nd, 2021